CBAN vs EOLS
CBAN: Colony Bankcorp is a regional bank holding company providing diverse commercial and consumer banking, mortgage, and small business lending services across the Southeastern United States. EOLS: A growth-oriented aesthetic beauty company disrupting the injectable market with a customer-centric, cash-pay model for neurotoxins and dermal fillers.
Side-by-side fundamentals
| Metric | CBAN | EOLS | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $20.34 | $7.35 | |
| Market cap | $432M | $485M | |
| P/E as of 2026-10-30 | 45.20 | n/a | |
| PEG as of 2026-10-30, 3-year EPS CAGR to FY2025 | 3.85 | n/a | |
| Net margin FY2025, SEC XBRL | n/a | -17.4% | |
| Gross margin FY2025, SEC XBRL | n/a | +66.3% | |
| Operating margin FY2025, SEC XBRL | n/a | -11.0% | |
| ROE FY2025, SEC XBRL | +7.5% | n/a | |
| ROA FY2025, SEC XBRL | +0.8% | -22.9% | CBAN higher |
| Revenue growth (YoY) FY2025, SEC XBRL | n/a | +11.6% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +26.0% | |
| Dividend yield as of 2026-09-03 | 2.36% | n/a | |
| Dividend streak (yrs) SEC XBRL | 9 | 0 | CBAN higher |
| Beta as of 2026-09-03 | 0.71 | 1.26 | |
| 1-year return as of 2026-10-30 close | +27.0% | +9.4% | CBAN higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.